Table 3 Psychiatric assessment among the studied group
From: Some psychiatric comorbidity among patients with substance abuse disorder related to pregabalin
Variable | (n = 83) | ||
|---|---|---|---|
No. | % | ||
Psychiatric comorbid | Generalized anxiety | 39 | 47 |
Major depression | 62 | 74.7 | |
Personality disorder | Borderline | 65 | 78.3 |
Antisocial | 31 | 37.3 | |
Beck depression inventory | Mean ± SD | 33.07 ± 17.86 | |
Median (IQR) | 37 (23–46) | ||
Range | 0–69 | ||
No | 17 | 20.5 | |
Mild depression | 2 | 2.4 | |
Moderate depression | 2 | 2.4 | |
Severe depression | 20 | 24.1 | |
Very severe depression | 42 | 50.6 | |
Hamilton anxiety | Mean ± SD | 16.98 ± 13.21 | |
Median (IQR) | 16 (4–28) | ||
Range | 0–46 | ||
| Â | No anxiety | 13 | 15.7 |
Mild | 29 | 34.9 | |
Mild to moderate | 16 | 19.3 | |
Moderate to severe | 7 | 8.4 | |
Very severe | 18 | 21.7 | |
Previous suicidal attempts | No | 62 | 74.7 |
Yes | 21 | 25.3 | |